✦ LIBER ✦

Relation between elevated high-sensitivity C-reactive protein and anti-mitochondria antibody in patients with systemic sclerosis

✍ Scribed by Tsutomu OHTSUKA

Book ID: 108576383
Publisher: John Wiley and Sons
Year: 2008
Tongue: French
Weight: 84 KB
Volume: 35
Category: Article
ISSN: 0385-2407
DOI: 10.1111/j.1346-8138.2008.00418.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum interleukin-6 level is reflected i

Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis

✍ Tsutomu OHTSUKA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB

The relation between high-sensitivity C-

The relation between high-sensitivity C-reactive protein and maximum body mass index in patients with psoriasis

✍ T. Ohtsuka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

High Prevalence of Chlamydia Pneumoniae

High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High-Sensitive C-Reactive Protein in Patients with Vascular Dementia

✍ Hideki Yamamoto; Takuya Watanabe; Akira Miyazaki; Takashi Katagiri; Tsunenori Id 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Erosive arthritis in systemic lupus eryt

Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies

✍ L. M. Amezcua-Guerra; R. Márquez-Velasco; R. Bojalil 📂 Article 📅 2008 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 69 KB

Antibodies to apolipoprotein A-I, high-d

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus

✍ Sean G. O'Neill; Ian Giles; Anastasia Lambrianides; Jessica Manson; David D'Cruz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

## Abstract ## Objective Inflammatory disease activity in patients with systemic lupus erythematosus (SLE) may affect the development of atherosclerosis, contributing to their increased risk of cardiovascular disease (CVD). This process may be mediated by anti–apolipoprotein A‐I (anti–Apo A‐I), an